- Home
- POAI vs NURO Comparison
POAI vs NURO Comparison
Compare POAI & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- NURO
- Stock Information
- Founded
- POAI 2002
- NURO 1996
- Country
- POAI United States
- NURO United States
- Employees
- POAI N/A
- NURO N/A
- Industry
- POAI Industrial Specialties
- NURO Medical/Dental Instruments
- Sector
- POAI Health Care
- NURO Health Care
- Exchange
- POAI Nasdaq
- NURO Nasdaq
- Market Cap
- POAI 9.7M
- NURO 9.0M
- IPO Year
- POAI N/A
- NURO N/A
- Fundamental
- Price
- POAI $1.12
- NURO $4.37
- Analyst Decision
- POAI Hold
- NURO
- Analyst Count
- POAI 1
- NURO 0
- Target Price
- POAI N/A
- NURO N/A
- AVG Volume (30 Days)
- POAI 415.6K
- NURO 7.3K
- Earning Date
- POAI 03-27-2025
- NURO 03-25-2025
- Dividend Yield
- POAI N/A
- NURO N/A
- EPS Growth
- POAI N/A
- NURO N/A
- EPS
- POAI N/A
- NURO N/A
- Revenue
- POAI $1,484,223.00
- NURO $3,767,764.00
- Revenue This Year
- POAI N/A
- NURO N/A
- Revenue Next Year
- POAI $569.48
- NURO N/A
- P/E Ratio
- POAI N/A
- NURO N/A
- Revenue Growth
- POAI N/A
- NURO N/A
- 52 Week Low
- POAI $0.55
- NURO $2.66
- 52 Week High
- POAI $3.06
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- POAI 41.00
- NURO 57.17
- Support Level
- POAI $1.02
- NURO $4.33
- Resistance Level
- POAI $1.15
- NURO $4.39
- Average True Range (ATR)
- POAI 0.09
- NURO 0.03
- MACD
- POAI -0.03
- NURO -0.01
- Stochastic Oscillator
- POAI 20.83
- NURO 33.33
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.